Binding molecules that inhibit cancer growth Grant US-11939394-B2 United States of America 26 Mar 2024
Methods and compositions for treating metastatic breast cancer and other cancers in the… Grant US-11865187-B2 United States of America 09 Jan 2024
Binding protein drug conjugates comprising anthracycline derivatives Grant US-11833120-B2 United States of America 05 Dec 2023
Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor Grant US-11820825-B2 United States of America 21 Nov 2023
ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that… Grant US-11780925-B2 United States of America 10 Oct 2023
TREATMENT OF CANCER Application WO-2023152335-A1 World Intellectual Property Organisation (WIPO) 17 Aug 2023
Receptor targeting constructs and uses thereof Grant US-11369687-B2 United States of America 28 Jun 2022
Cysteine engineered antibody drug conjugates Grant US-11364303-B2 United States of America 21 Jun 2022
Method of producing an immunoligand/payload conjugate Grant US-11364301-B2 United States of America 21 Jun 2022
SPECIFIC SIRNA MOLECULES, COMPOSITION AND USE THEREOF FOR THE TREATMENT OF TRIPLE… Application EP-3936136-A1 European Patent Office 12 Jan 2022
Engineered antibody constant regions for site-specific conjugation and methods and uses… Grant US-11147852-B2 United States of America 19 Oct 2021
Binding protein drug conjugates comprising anthracycline derivatives Grant US-10960083-B2 United States of America 30 Mar 2021
Method of producing an immunoligand/payload conjugate Grant US-10864277-B2 United States of America 15 Dec 2020
Methods and compositions for treating metastatic breast cancer and other cancers in the… Grant US-10780182-B2 United States of America 22 Sep 2020
METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING A HUMAN ERBB-2 MUTANT PROTEIN Application WO-2020161614-A1 World Intellectual Property Organisation (WIPO) 13 Aug 2020
Recombinant binding proteins targeting HER2 and serum albumin, and their uses Grant US-10717772-B2 United States of America 21 Jul 2020
Site specific HER2 antibody drug conjugates Grant US-10689458-B2 United States of America 23 Jun 2020
Metodo per classificare pazienti affetti da tumore alla mammella idonei per immunoterapia Application IT-201800010730-A1 Italy 30 May 2020
Binding protein drug conjugates comprising anthracycline derivatives Grant US-10517959-B2 United States of America 31 Dec 2019
Binding protein drug conjugates comprising anthracycline derivatives Application US-10188745-B2 United States of America 29 Jan 2019
Receptor targeting constructs and uses thereof Grant US-10183078-B2 United States of America 22 Jan 2019
Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle Grant US-9850293-B2 United States of America 26 Dec 2017
METHODS OF TREATING HER2-POSITIVE CANCER Application WO-2017087280-A1 World Intellectual Property Organisation (WIPO) 26 May 2017
HER2 BINDING AGENT THERAPIES Application WO-2016162505-A1 World Intellectual Property Organisation (WIPO) 13 Oct 2016